Drug Shortage Report for CALMYLIN PSE WITH CODEINE
| Report ID | 195521 |
| Drug Identification Number | 02172917 |
| Brand name | CALMYLIN PSE WITH CODEINE |
| Common or Proper name | CALMYLIN PSE WITH CODEINE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | GUAIFENESIN PSEUDOEPHEDRINE HYDROCHLORIDE CODEINE PHOSPHATE |
| Strength(s) | 100MG 30MG 3.3MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL ORAL |
| Packaging size | 250ML |
| ATC code | R05FA |
| ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-19 |
| Estimated end date | 2023-06-30 |
| Actual end date | 2023-07-05 |
| Shortage status | Resolved |
| Updated date | 2023-07-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-07-06 | English | Compare |
| v5 | 2023-07-05 | French | Compare |
| v4 | 2023-07-05 | English | Compare |
| v3 | 2023-06-20 | English | Compare |
| v2 | 2023-06-19 | French | Compare |
| v1 | 2023-06-19 | English | Compare |
Showing 1 to 6 of 6